Reaction
Bacterial Endophthalmitis reporting signals
As of the last recalculation, Bacterial Endophthalmitis appears in 251 FAERS reports alongside 6 co-occurring drug terms. The strongest observed disproportionality signal is AFLIBERCEPT (PRR 178.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Aflibercept | 53 | 178.3 | 178.6 |
| Faricimab | 9 | 95.5 | 95.6 |
| Bevacizumab | 82 | 81.1 | 81.1 |
| Anti-Thymocyte Globulin (Rabbit) | 5 | 52.4 | 52.5 |
| Ranibizumab | 13 | 42.8 | 42.8 |
| Remdesivir | 5 | 31.7 | 31.7 |